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Abstract
Introduction: Our previous study revealed that anti-inflammatory cytokine gene
polymorphisms increase the risk of spontaneous preterm delivery (PD) in 
a population of Polish women. Different genetic background of PD due to
preterm premature rupture of membranes (pPROM) than PD without pPROM
has been suggested. The aim of this study was to examine the relationship
between the maternal carriage of polymorphic alleles of the following genes:
interleukin 1β(IL-1β [+3953C>T]), interleukin 6 promoter (IL-6 [–174G>C]), tumour
necrosis factor promoter (TNF-α [–308G>A]) and interleukin 1 receptor antagonist 
(IL-1RN) and the risk of PD caused exclusively by pPROM in a population of Polish
women. 
Material and methods: A case-control study. 95 Caucasian women were
examined including 32 cases and 63 controls. Case subjects experienced 
a delivery at less than 36 weeks and 6 days of gestation due exclusively to
pPROM while control subjects gave birth at term. Polymorphisms were
determined by polymerase chain reaction-restriction fragment length
polymorphism analysis (PCR-RFLP). 
Results: No statistically significant relationship between polymorphisms of
examined genes and risk of PD due to pPROM in a population of Polish women
was found: OR = 0.84 (95% CI: 0.34-2.01) for IL-1β, OR = 0.77 (95% CI: 0.27-2.13)
for IL-6, OR = 0.72 (95% CI: 0.26-1.90) for TNF-α and OR = 1.74 (95% CI: 
0.66-4.64) for IL-1RN. 
Conclusions: Maternal carriage of polymorphic alleles of IL-1β, IL-6 promoter,
TNF-α promoter and IL-1RA seems to have no impact on the risk of PD due to
pPROM in the population of Polish women.The genetic contribution and
pathomechanism of PD related to pPROM seems to differ from those of
spontaneous PD without pPROM.  
Key words: cytokines, prematurity, genetic polymorphism, pathomechanism.
Introduction
Preterm premature rupture of membranes (pPROM) is a rupture of fetal
membranes which appears before 37 weeks of gestation and before onset
of uterus contractions. Up to 50% of preterm deliveries are preceded by
pPROM [1]. Ascending infections of the lower genital tract, such as bacterial
vaginosis (BV), which may lead to chorioamnionitis and intrauterine
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infections are thought to be the most important
cause of pPROM [2]. In these states macrophages
present in maternal, fetal and placental tissues
undergo activation and produce a number of
cytokines, among them interleukin-1β (IL-1β),
interleukin-6 (IL-6) and tumour necrosis factor-α
(TNF-α) [3, 4]. These cytokines are able to stimulate
production of prostaglandins by amnion, chorion
and deciduas [5, 6]. Prostaglandins provoke uterine
contractility which can lead to premature
membrane rupture. One of the major anti-
inflammatory agents encoded by the IL-1RN gene
is IL-1 receptor antagonist (IL-1RA), which is 
a natural competitive inhibitor of IL-1β activity [7].
IL-1RA terminates IL-1β induced inflammation [8].
In mice models pre-treatment with this cytokine
prevented IL-1-induced preterm parturition [9]. 
In in vitro studies it also reduces IL-1-induced
prostaglandin production by amnion and chorion [10]. 
There are some differences among individuals in
the intensity of the inflammatory response to
infectious agents [3, 4, 6, 8, 10]. These differences
can be caused by polymorphism of genes encoding
for pro and anti-inflammatory cytokines. The gene
polymorphism manifests itself in simultaneous
presence in the population of different allelic forms
of selected genes. Polymorphisms can concern a
single nucleotide (SNP – single nucleotide
polymorphism) related to deletion, insertion or
substitution of a single nucleotide, or a longer,
repeatedly appearing satellite sequence.  
Genes encoding for IL-1β, IL-6, TNF-α are
polymorphic. Single nucleotide polymorphism in
position +3953 of the gene encoding for IL-1β
containing a C by T substitution results in
appearance of the rarer allele 2 (IL-1β+3953*2). 
This allele is associated with the enhanced
production of IL-1β in vitro [11]. Single nucleotide
polymorphism at position –174 in a promoter region
of IL-6 connected with substitution of C for G is
associated with decrease in promoter activity. The
C/C variant is related to reduced IL-6 production,
whereas homozygous G/G or heterozygous G/C
displays normal production of IL-6 [12]. The
substitution of A for G at position -308 in a
promoter region of TNF-α genes leads to creation
of a rarer allele (TNF-α-308*2). Carriage of these
allele is associated with increased TNF-α gene
expression in comparison to homozygous G/G [13].
Gene encoding for IL-1RA (IL-1RN) is also
polymorphic. A region within intron 2 of this gene
contains a variable number of 86-base pair tandem
repeats, which results in 5 alleles. The alleles 1, 2,
3, 4 and 5 represent four, two, five, three and six
repeats of 86-bp tandem repeats, respectively [14].
The most prevalent in the general population is
allele 1 (IL-1RN*1), while allele 2 (IL-1RN*2) occurs
less often. Remaining alleles IL-1RN*3, IL-1RN*4, 
IL-1RN*5 are present in less than 1% of the
population. Carriage of IL-1RN*2 is associated with
higher IL-1RA and IL-1β concentration in plasma [15].  
The results of our previous study suggest that
maternal carriage of allele 2 of the IL-1RA gene
increases the risk of preterm delivery due to preterm
labour not preceded by pPROM in the population of
Polish women [16]. This time it was decided to
investigate whether this relationship is also valid for
PD related exclusively to pPROM. The decision to
undertake these two matters separately resulted
from a suggestion that PD due to pPROM and PD
related to preterm labour constitute two aetiologically
distinct diseases [17]. We were interested to discover
whether these differences also apply to genetic
conditions of PD. 
The aim of the current study was to evaluate 
the relationship between maternal carriage of
polymorphic alleles of the following genes: IL-1β
(IL-1β [+3953C>T]), IL-6 promoter (IL-6 [–174G>C]),
TNF-α promoter (TNF-α [–308G>A]) and IL-1RN 
and the risk of PD due exclusively to pPROM in 
a population of Polish women.
Material and methods
The study was approved by the Committee for
Bioethics of the Medical University of Łódź (number
RNN/29/04/KE). Written informed consent was
obtained from all patients.
Ninety-five Caucasian women who delivered in
the Department of Perinatology, First Chair of
Gynaecology and Obstetrics, Medical University of
Lodz between 2005 and 2007 were included in the
study. Women were divided into two groups. Cases
were defined as those who delivered a child at less
than 366 weeks of gestation due to preterm
premature rupture of membranes. Control subjects
were defined as women who delivered after 37
weeks’ gestation. In all women gestational age was
estimated based on the date of the last period and
confirmed by the ultrasound evaluation performed
between 11 and 13+6 weeks of pregnancy. Mothers
with incompetent cervix, congenital anomalies of
uterus, fetal malformations, iatrogenic preterm
delivery and preterm delivery resulting from preterm
labour without pPROM were excluded from the
study. Clinical and demographic information was
collected by chart review and patient self-reports. 
Maternal genomic DNA was isolated from white
cells of peripheral blood obtained after delivery
according to Higuchi. Polymerase chain reaction (PCR)
was carried out using the GeneAmp PCR System
2007 and GeneAmp PCR system 2400 (Applied
Biosystems, USA) following the manufacturer’s
recommendations. 
In order to analyse IL-1β+3953 allelic variants the
polymorphic region containing the Taq I restriction
site was amplified with the following primers: 
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5’-GTTGTCATCAGACTTTGACC-3’ and 5’-TTCAGTTCA
TAT  G  GACCAGA-3’. PCR conditions consisted of 
a denaturing step at 95°C for 5 min followed by 30
cycles of 94°C for 1 min, 58°C for 1 min and 72°C for
1 min. Eight millilitres of PCR product was digested
with TaqI (Fermentas, Canada) at 65°C for 24 h. TaqI
digestion of the 249-bp fragments results in
products that either are cut into 2 fragments of 135
bp and 11 bp (IL-1β+3953*1) or remain intact 
(IL-1β+3953*2). 
Interleukin-6 promoter region was amplified with
oligonucleotides 5’-TCCCCCTAGTTGTGTCTGGCG-3’,
5’-CTGCACTTTATCCCCTAGTTGTGTCATGCC-3’ and 
5’-TGAGGGTGGGGCCAGAGA-3’. The PCR included
40-s denaturation at 95°C followed by 35 ampli  -
fication cycles (40 s at 95°C, 45 s at 63°C and 40 s
at 72°C). The size of digestion products was 94 bp
for allele G and 103 bp for allele C.  
Tumour necrosis factor-α promoter was amplified
by polymerase chain reaction with primers 5’-GGCAA
TAGGTTTTGAGGGCCAT-3’ and 5’-TCCTCCCTGCTCCGA
TTCCG-3’. Cycling was performed at 94°C for 4 min;
then for 30 cycles of 94°C for 40 s, 60°C for 40 s and
72°C for 40 s. Polymerase chain reaction products were
digested overnight at 37°C with NcoI (Fermentas). The
size of the digestion products was 87 bp and 20 bp for
TNF-α*1 and 107 bp for TNF-α*2. 
Oligonucleotides 5’-CTCAGCAACACTCCTAT-3’ and
5’-TCCTGGTCGCAGGTAA-3’ were used as PCR
primers in order to analyse allelic variants in intron
2 of IL-1RN. The PCR conditions were as follows: 
1 cycle at 95°C for 5 min, followed by 40 cycles of
94°C for 1 min, 63°C for 1 min and 72°C for 1 min.
Polymerase chain reaction products were 410 bp 
(IL-1RN*1), 240 bp (IL-1RN*2) and 500 bp (IL-1RN*3)
in size. All DNA fragments were analysed on 10%
polyacrylamide gels with Mini Protein II and Mini
Protein III equipment (Bio-Rad, USA) and stained
with ethidium bromide (Figure 1). 
Genotype frequencies in study and control
groups were compared using an exact logistic
regression model. Analysis was used to estimate
the odds ratio (OR) and its 95% confidence intervals
(95% CI). Analysis was performed with the
statistical analysis package R version 2.7.2
(http://www.r-project.org). Assuming the power of
the test as 0.80 and level of significance α = 0.05
with a population size of 95 women, OR of 3.7 or
above will be detected as significant.
Results
We studied 32 women with PD due to pPROM
occurring before 366 weeks’ gestation and 63
women who delivered at or after 37 weeks’
gestation (reference group). There was no difference
in the percentage of caesarean sections performed,
maternal age and weight at delivery between term
and preterm subjects. In the study group
significantly more women smoked cigarettes and
had a history of at least one preterm delivery than
in the control group. As defined by our parameters,
the mean gestational age at delivery and the mean
newborn birth weight were significantly lower
among women who delivered prematurely. These
data are illustrated in Table I.
The frequency of polymorphic allele 2 of the 
IL-1β gene was 43.8% in women who gave birth to
a premature baby and 51.8% in women who
delivered at term. We found no statistically
significant influence of polymorphism of the IL-1β
(+3953C>T) gene on the risk of PD as a result of
pPROM, OR = 0.84 (95% CI: 0.34-2.01).
The analysis of frequencies of individual
genotypes of IL-6 gene promoter shows CC, GC and
GG genotype in 40.6%, 31.3%, and 28.1% of case
subjects and 39.6%, 39.6%, and 20.8% of control
subjects respectively. No statistically significant
410 bp
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Figure 1. Methods of allelic variants identification of
IL-1RA gene
Parameter Preterm delivery (n = 32) Term delivery (n = 63) Value of p
Maternal age at delivery [years] 31.2 29.0 NS
Mean maternal weight at delivery [kg] 75.0 74 NS
Smoking during pregnancy [%] 31.0 17.5 < 0.05
History of preterm delivery [%] 20.7 4.6 < 0.05
Percentage of caesarean section [%] 31.0 31.7 < 0.05
Gestational age at delivery [week] 32.2 39.2 < 0.05
Newborns’ birth weight [g] 1980 3470 < 0.05
Table I. Demographic characteristics of examined population
Adam Bitner, Jaroslaw Kalinkainfluence of IL-6 gene promoter polymorphism on
the risk of PD due to pPROM was found. Odds ratio
and its 95% CI for GC genotype were OR = 0.77
(95% CI: 0.27-2.13) and for GG genotype OR = 1.32
(95% CI: 0.43-4.08).
In both groups of women the most frequent
genotype was IL-1RN*1/IL-1RN*1. Among women
who delivered before term it was found in 43.8%
while among women who delivered at term this
genotype was more frequent (56.6% of women). 
The genotype IL-1RN*1/IL-1RN*2 was present in
40.6% of the study group and 30.2% in controls. In
the remaining women we detected IL-1RN*2/IL-1RN*2
genotype or other rare genotypes: IL-1RN*1/IL-1RN*3,
IL-1RN*2/IL-1RN*3. We did not reveal a statistically
significant influence of IL-1RA gene polymorphism
on the risk of pPROM and subsequent PD. Odds ratio
for pPROM occurrence in women who carried one
polymorphic allele 2 (IL-1RN*2) was OR = 1.74 
(95% CI: 0.66-4.64) and in the case of carriage of two
polymorphic alleles 2 or allele 3 (IL-1RN*3) OR = 1.53
(95% CI: 0.39-5.67).
When we analysed the frequency of individual
genotypes of the TNF-α gene we found that in both
groups of women the most frequent genotype was
TNF-α*1/TNF-α*1. We found this genotype in 75%
of women who delivered prematurely and in 68.5%
of women who delivered at term. No statistically
significant relationship between carriage of
polymorphic allele 2 of the TNF-α gene (TNF-α*2)
and the risk of preterm delivery as a result of
pPROM was found, OR = 0.72 (95% CI: 0.26-1.90).
Results are illustrated in Figure 2.
Discussion
According to our knowledge this is one of the
first studies where the relationship between
maternal carriage of polymorphic alleles of pro and
anti-inflammatory cytokines and the risk of PD
resulting exclusively from pPROM was analysed. In
our research we have not identified a statistically
significant influence of maternal carriage of
polymorphic genes encoding for IL-1β, IL-6 promoter,
TNF-α promoter and IL-1RA on the risk of preterm
delivery caused exclusively by preterm premature
rupture of membranes. 
Until now the majority of authors have studied
the relationship between gene polymorphisms and
the risk of PD regardless of the cause. Most
researchers agree that both maternal and fetal
carriage of allele 2 of the IL-1RA gene increases the
risk of spontaneous preterm delivery [3, 7, 18]. In
contrast, the impact of polymorphisms of remaining
genes that we have examined, i.e. IL-1β, IL-6
promoter, and TNF-α promoter, on the risk of
prematurity is being negated [12, 19, 20]. In our
previous study we revealed that maternal carriage
of IL-1RN allele 2 significantly increases the risk of
preterm delivery due to preterm contractions, not
preceded by pPROM in the population of Polish
women, OR = 3.12 (95% CI: 1.14-9.00) [16]. It seems
that lack of an influence of IL-1RN gene
polymorphism on the risk of PD due to pPROM and
at the same time a distinct impact of this
polymorphism on the risk of spontaneous preterm
delivery, due to uterus contractions not preceded
by pPROM, might indicate that these two states
have different pathomechanisms and different
genetic contributions. These observations seem to
confirm the findings reported by Roberts et al. [21].
These authors did not identify a statistically
significant impact of carriage of a polymorphic allele
of the TNF-α promoter gene on the risk of PD.
However, they observed that the rarer allele TNF-α*2
was more common in women who delivered
prematurely due to pPROM compared to women in
whom PD was not associated with pPROM, OR =
3.18 (95% CI: 1.33-7.83). Menon et al. even suggest
that PD due to pPROM and PD without pPROM
should be considered as two separate diseases due
to different aetiology [20].  
A few authors have tried to explain the
relationship between the carriage of polymorphic
alleles of genes encoding for cytokines and the risk
of PD due to pPROM. Kalish et al. in a study carried
out in the US revealed that fetal carriage of 
IL-1RN*2 was associated with increased risk of
pPROM and subsequent PD [7]. Our research does
not show these relationships in a population of
Polish women. In a study carried out in a population
of Afro-American women, the authors demon  -
strated that carriage of a polymorphic allele of the
TNF-α gene increases the risk of pPROM [21]. Tumour
necrosis factor-α is able to stimulate numerous
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Figure 2. Relationship between selected cytokine
genotype and the risk of PD due to pPROM in the
population of Polish women. Data statistically not
significant
Genotype
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tissues, among them fetal membranes and cervix
uteri, to produce matrix metalloproteinases (MMP),
which are able to degrade collagen. The degradation
of collagen in fetal membranes and in cervix uteri
might be responsible for preterm premature rupture
of membranes and dilatation of the cervix. These
data suggest that the presence of the polymorphic
allele TNF-α*2, which is associated with higher
expression of the TNF-α gene, might increase the
risk of pPROM. Our findings do not confirm this
hypothesis in a population of Polish women. The
different results are probably associated with ethnic
disparity. Many authors have emphasized the
distinct influence of individual allelic variants on
the risk of preterm delivery in different populations
[22, 23]. Genç et al. revealed that fetal carriage of
allele 1 of the IL-1α gene increases the risk of
preterm delivery in Afro-American women, but
carriage of allele 2 of this gene is associated with
higher risk of prematurity in women of Hispanic
origin [3]. Dissimilar influence of allelic variants in
distinct populations might be associated with the
extremely high number of SNP in the human
genome and with interactions between these
polymorphisms. It has been estimated that there
are approximately 200 000 single nucleotide
polymorphisms within the encoding regions of the
80 000 human genes [3]. Recent studies have
shown that the carriers of polymorphic alleles of
TLR4 (Toll-like receptor 4), which plays a
fundamental role in pathogen recognition and
activation of innate immunity, are at increased risk
of pPROM and subsequent PD [24]. It has also been
revealed that the carriage of polymorphic alleles
encoding for MMP1 (matrix metalloproteinase 1), a
protein involved in the breakdown of extracellular
matrix, influences the risk of pPROM [25]. 
We realize that our research is limited by the
small groups and by the power of the study. Further
larger studies conducted on a prospective basis are
necessary to elucidate differences in patho  -
mechanism and genetic contributions between PD
related and not related to pPROM. 
In conclusion, it should be said that individual
genes interacting with numerous polymorphic
alleles might have a different influence on the
duration of pregnancy. We can hope that in future
it will be possible to define a group of genes
responsible for preterm delivery in specific
populations. This would allow us to identify patients
at high risk for giving birth to a premature baby so
that prevention programmes could be implemented
before any symptoms of preterm delivery appear. 
The genetic contributions and pathomechanism
of PD related exclusively to pPROM seem to differ
from those of spontaneous PD without pPROM.
Maternal carriage of polymorphic alleles of IL-1β,
IL-6 promoter, TNF-α promoter and IL-1RA genes
seems to have no impact on risk of PD due to
pPROM, while carriage of IL-1RN allele 2 probably
increases the risk of prematurity in the population
of Polish women.
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